Hubei Jumpcan Pharmaceutical Co Ltd (600566) — Cash Flow Quality Index
Hubei Jumpcan Pharmaceutical Co Ltd (600566) has a Cash Flow Quality Index of -0.82x as of September 2025. Operating cash flow of CN¥-243.75 Million is below net income of CN¥298.10 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore 600566 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hubei Jumpcan Pharmaceutical Co Ltd Cash Flow Quality Index (2000–2024)
Historical Cash Flow Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600566 tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hubei Jumpcan Pharmaceutical Co Ltd (2000–2024)
Year-by-year earnings quality comparison for Hubei Jumpcan Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see Hubei Jumpcan Pharmaceutical Co Ltd (600566) total market value.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 0.86x | CN¥2.18 Billion | CN¥2.54 Billion | ▼ -30.1% |
| 2023 | 1.23x | CN¥3.46 Billion | CN¥2.82 Billion | ▲ +1.7% |
| 2022 | 1.21x | CN¥2.62 Billion | CN¥2.17 Billion | ▲ +9.4% |
| 2021 | 1.10x | CN¥1.89 Billion | CN¥1.72 Billion | ▼ -20.9% |
| 2020 | 1.39x | CN¥1.78 Billion | CN¥1.28 Billion | ▲ +5.4% |
| 2019 | 1.32x | CN¥2.15 Billion | CN¥1.62 Billion | ▲ +30.7% |
| 2018 | 1.01x | CN¥1.71 Billion | CN¥1.69 Billion | ▲ +4.3% |
| 2017 | 0.97x | CN¥1.19 Billion | CN¥1.22 Billion | ▼ -0.6% |
| 2016 | 0.98x | CN¥913.10 Million | CN¥934.36 Million | ▲ +3.4% |
| 2015 | 0.94x | CN¥645.48 Million | CN¥683.12 Million | ▼ -20.3% |
| 2014 | 1.19x | CN¥616.11 Million | CN¥519.39 Million | ▲ +66.4% |
| 2013 | 0.71x | CN¥287.16 Million | CN¥402.72 Million | ▲ +1276.0% |
| 2011 | 0.05x | CN¥411.24K | CN¥7.94 Million | ▼ -99.1% |
| 2010 | 6.03x | CN¥51.13 Million | CN¥8.48 Million | ▲ +847.4% |
| 2009 | 0.64x | CN¥4.92 Million | CN¥7.73 Million | ▼ -76.8% |
| 2008 | 2.74x | CN¥23.05 Million | CN¥8.42 Million | ▼ -18.7% |
| 2007 | 3.37x | CN¥36.72 Million | CN¥10.90 Million | ▲ +610.4% |
| 2006 | 0.47x | CN¥4.24 Million | CN¥8.95 Million | ▼ -93.7% |
| 2005 | 7.49x | CN¥63.38 Million | CN¥8.46 Million | ▲ +248.0% |
| 2004 | -5.06x | CN¥-37.74 Million | CN¥7.45 Million | ▼ -1775.7% |
| 2003 | 0.30x | CN¥2.24 Million | CN¥7.42 Million | ▼ -80.9% |
| 2002 | 1.58x | CN¥22.00 Million | CN¥13.89 Million | ▲ +277.6% |
| 2001 | 0.42x | CN¥7.43 Million | CN¥17.70 Million | ▼ -74.3% |
| 2000 | 1.63x | CN¥23.73 Million | CN¥14.55 Million | — |